Leiutis receives CDSCO approval for the world`s first synthetic cannabidiol oral solution for anxiety disorders in India.

Cannabidiol (CBD) is a naturally occurring compound found in cannabis. Unlike THC, it is not intoxicating and does not produce the “high” typically associated with cannabis. CBD interacts with the ...

In the phase 2 LiBBY trial presented, tetrahydrocannabinol and cannabidiol reduced agitation scores and improved clinician-rated outcomes in patients with advanced dementia.

The Francis College of Engineering, Department of Mechanical Engineering, invites you to attend a Doctoral Dissertation Mechanical Engineering defense by Alana Griggs entitled, "Advancing Life Cycle ...

Recent research published in the Journal of Psychopharmacology suggests that cannabidiol, a non-intoxicating compound found ...

A Phase II trial found that a THC-CBD oral formulation may reduce agitation in people with advanced dementia, but larger ...

Texas will ban delta-8, delta-10, THCP and other hemp products July 31. Here's what remains legal after the Supreme Court ...

Song Beam Bedding Co., Ltd., a premier sleep solutions provider in Taiwan, announced that a clinical sleep research project it sponsored—led by Chinese medicine and pharmacology expert Juan-Cheng Yang ...

High hopes for those with dementia. New research has found an unexpected benefit for a common symptom in those with ...

Ananda Pharma Limited is a UK-based biopharmaceutical company developing regulatory approved cannabidiol medicines to treat complex, chronic conditions. It has lead programmes in endometriosis and ...

Families caring for loved ones with advanced dementia and severe agitation now have a new piece of clinical evidence to weigh ...

"Why would you repeat those damn lies? That destroys trust." -- Sen. Bill Cassidy, MD (R-La.), grilling President Trump's ...